Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17316270 | 0.84 | EPHX2 (0.68) | EPHX2EPHX1 | |
| SCHEMBL25933285 | 0.83 | EPHX2 (0.46) | EPHX2EPHX1 | |
| SCHEMBL26251778 | 0.81 | EPHX2 (0.64) | EPHX2EPHX1 | |
| SCHEMBL25930914 | 0.81 | EPHX2 (0.64) | EPHX2EPHX1 | |
| SCHEMBL13306160 | 0.79 | EPHX2 (0.62) | EPHX2EPHX1 | |
| SCHEMBL12507086 | 0.79 | EPHX2 (0.62) | EPHX2EPHX1 | |
| SCHEMBL27969934 | 0.79 | EPHX2 (0.62) | EPHX2EPHX1 | |
| SCHEMBL2719520 | 0.79 | EPHX2 (1.00) | EPHX2EPHX1 | |
| SCHEMBL2730613 | 0.79 | EPHX2 (1.00) | EPHX2EPHX1 | |
| SCHEMBL27726136 | 0.79 | GAA (0.63) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118019728-A | Compounds as soluble epoxide hydrolase inhibitors | 巴塞罗那大学 | 2024-05-10 | — | — | CN | claimed |
| CN-112888674-B | Polycyclic compounds as soluble epoxide hydrolase inhibitors | 巴塞罗那大学 | 2023-06-30 | — | — | CN | claimed |
| CN-118019728-A | Compounds as soluble epoxide hydrolase inhibitors | 巴塞罗那大学 | 2024-05-10 | — | — | CN | disclosed |
| CN-112888674-B | Polycyclic compounds as soluble epoxide hydrolase inhibitors | 巴塞罗那大学 | 2023-06-30 | — | — | CN | disclosed |
| WO-2023012610-A1 | FORMULATIONS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF STROKE | AVACA PHARMA PRIVATE LIMITED (IN) | 2023-02-09 | — | — | WO | disclosed |